Raksha Jain - Concepedia

Author

Raksha Jain

The University of Texas Southwestern Medical Center ORCID

Also Known As

Edith Zemanick, Jain R, R Jain, R K Jain, R. Jain, Raksha Jain, Ronak Jain, Steven L Brody

160

Publications

6.8K

Citations

H-Index

104

Concepts

All Affiliations

The University of Texas Southwestern Medical Center University of Colorado Denver University of Washington National Jewish Health Cystic Fibrosis Foundation

About

Raksha Jain is an author at The University of Texas Southwestern Medical Center specializing in medicine, public health, and pulmonary fibrosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	27	2.8K
2	Public Health	7	7	311
3	Health Sciences	2	2	72
4	Engineering	1	1	35
5	Social Sciences	1	1	17

Raksha Jain

Publications

5.9K

Citations

H-Index

Page 1

	Year	Citations
Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele Peter G. Middleton, Marcus Mall, Pavel Dřevı́nek, New England Journal of Medicine	2019	2K
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial Harry Heijerman, Edward F. McKone, D.G. Downey, The Lancet Mendelian DisorderGeneticsIvacaftor Combination RegimenF508del MutationMedicine	2019	1.3K
Gender Differences in Outcomes of Patients with Cystic Fibrosis Cayce L. Harness‐Brumley, Alan C. Elliott, Daniel Rosenbluth, Journal of Women s Health	2014	192
Temporal Relationship between Primary and Motile Ciliogenesis in Airway Epithelial Cells Raksha Jain, Jiehong Pan, James A. Driscoll, American Journal of Respiratory Cell and Molecular Biology Motile CiliaPathologyOrgan DevelopmentCellular PhysiologyTissue Development	2010	160
Endothelin-1 Induces Alveolar Epithelial–Mesenchymal Transition through Endothelin Type A Receptor–Mediated Production of TGF-β1 Raksha Jain, Philip W. Shaul, Zea Borok, American Journal of Respiratory Cell and Molecular Biology Endothelin TypeImmunologyInflammationAngiogenesisTissue Development	2007	150
In vivo editing of lung stem cells for durable gene correction in mice Yehui Sun, Sumanta Chatterjee, Xizhen Lian, Science In Vivo Gene TherapyVivo EditingRegenerative MedicineDurable Gene CorrectionVivo Genome Correction	2024	132
Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome Raksha Jain, Ramsey R. Hachem, Matthew R. Morrell, The Journal of Heart and Lung Transplantation TransplantationMedicineRespiratory InfectionInfectious Respiratory DiseaseBronchiolitis Obliterans	2010	129
Sex Hormone–Dependent Regulation of Cilia Beat Frequency in Airway Epithelium Raksha Jain, Jennifer Ray, Jie-Hong Pan, American Journal of Respiratory Cell and Molecular Biology	2011	119
Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials Nicole Mayer-Hamblett, Félix Ratjen, Renee Russell, The Lancet Respiratory Medicine MedicineHypertonic SalineDornase AlfaPulmonary Fibrosis	2022	116
KB001-A, a novel anti-inflammatory, found to be safe and well-tolerated in cystic fibrosis patients infected with Pseudomonas aeruginosa Raksha Jain, Valeria Beckett, Michael W. Konstan, Journal of Cystic Fibrosis InflammationMedical MicrobiologyAntimicrobial SusceptibilityAntibioticsMedicine	2017	103

Page 1